HARALD HAMPEL

MD, PhD, MSc

Dr. Hampel is the Founding President of the Alzheimer Precision Medicine Initiative (APMI)

​

Dr. Hampel’s major research contributions include the discovery and development of multimodal genetic, biochemical, neurodynamic and neuroimaging biomarkers of neurodegenerative diseases. His major objective is to transform traditional Neurology, Psychiatry and Neuroscience embracing Precision Medicine and Pharmacology based on Complex Systems Theory using advanced Biostatistics, Genomics, Systems Biology and Neurophysiology, Big Data Science and Biomarker-guided integrative disease modeling for improved detection, classification, stratification and biomarker-guided “liquid-biopsy” targeted therapy development in neurodegenerative diseases, such as Alzheimer's disease.

​

APMI administrative committee *

​

Founding President:  H. Hampel, MD, PhD, MSc

​

Scientific Director: S. Lista, PhD 

Medical Director: A. Vergallo, MD

​

Structural Neuroimaging: E. Cavedo, PhD

Functional Neuroimaging: P.A. Chiesa, PhD

​

Data Science: P. Lemercier, MSc

* The views expressed on the APMI website (https://www.apmiscience.com/) are our own. They have not been reviewed or approved by our individual institutions and employers. 

©2020 by APMI